Company profilePharmaceutical#306 of 1,318 in Pakistan1 DRAP alert

RORYAN PHARMACEUTICAL INDUSTRIES (PVT) LTD

Pharmaceutical company · 58 brands · 46 molecules

Ranked #29 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

58 registered products 27 pharmaceutical brands 46 distinct molecules 1 DRAP alert

Company overview

58
registered products
27
pharmaceutical brands
46
distinct molecules
12
therapeutic classes
1
DRAP alerts

RORYAN PHARMACEUTICAL INDUSTRIES (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 58 product registrations across 46 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Quinolone Antibacterials. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Cefixime3 brands
Diclofenac3 brands
Paracetamol3 brands
Sparfloxacin2 brands
Cefadroxil2 brands
Pefloxacin2 brands
Norfloxacin2 brands
Loratadine2 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 8Quinolone Antibacterials · 7Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 5Antiinflammatory And Antirheumatic Products · 4Antihistamines For Systemic Use · 3Antidepressants · 2Antianemic, Iron & All Combination · 2Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1Antianemic, Iron Preparations · 1Cough And Cold Preparations · 1Other Analgesics And Antipyretics · 1Antispasmodic & Anticholinergic · 1

Regulatory record

1 alert in the DRAP feed we track.

Rapid Alert: Counterfeit and Unregistered Paracetol 500mg Tablets identified in the Market
2023-04-10

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for RORYAN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.